MarketResearchReports.Biz
announces addition of new report" Post Menopausal Osteoporosis
Global Clinical Trials Review, H2, 2016 "to its database.
GlobalData's clinical trial
report, Post Menopausal Osteoporosis Global Clinical Trials Review,
H2, 2016" provides an overview of Post Menopausal Osteoporosis
clinical trials scenario. This report provides top line data relating
to the clinical trials on Post Menopausal Osteoporosis. Report
includes an overview of trial numbers and their average enrollment in
top countries conducted across the globe. The report offers coverage
of disease clinical trials by region, country (G7 & E7), phase,
trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of
ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The report enhances the
decision making capabilities and helps to create an effective counter
strategies to gain competitive advantage.
View
Report :
http://www.marketresearchreports.biz/analysis/871685
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/871685
Table
of Contents
Table
of Contents
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing
to Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Countries Contributing to
Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing
to Clinical Trials in Central and South America 13
Clinical Trials by G7
Countries: Proportion of Post Menopausal Osteoporosis to Metabolic
Disorders Clinical Trials 14
Clinical Trials by Phase in G7
Countries 15
Clinical Trials in G7 Countries
by Trial Status 16
Clinical Trials by E7
Countries: Proportion of Post Menopausal Osteoporosis to Metabolic
Disorders Clinical Trials 17
Clinical Trials by Phase in E7
Countries 18
Clinical Trials in E7 Countries
by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status
22
Clinical Trials by End Point
Status 23
Subjects Recruited Over a
Period of Time 24
Clinical Trials by Sponsor Type
25
Prominent Sponsors 26
Top Companies Participating in
Post Menopausal Osteoporosis Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on
Post Menopausal Osteoporosis 30
Sep 18, 2016: Results From
Phase 3 FRAME Study Of Romosozumab Showed Significant Reductions In
Both New Vertebral And Clinical Fractures In Postmenopausal Women
With Osteoporosis 30
Sep 18, 2016: Radius Announces
Publication of Additional Positive Results from the Phase 3 ACTIVE
Trial of Abaloparatide-SC in JBMR 31
Sep 14, 2016: Amgen to present
romosozumab at Investor Call 32
Sep 07, 2016: UCB to present
results from Phase 3 FRAME Study at the American Society for Bone and
Mineral Research Annual Meeting 32
Aug 16, 2016: JAMA Publishes
Positive Phase 3 Data for Abaloparatide in Postmenopausal Women With
Osteoporosis 33
Jul 20, 2016: Radius Health
Announces Multiple Presentations at the American Society for Bone and
Mineral Research 2016 Annual Meeting September 16-19, 2016 34
Clinical Trial Profile
Snapshots 35
Appendix 319
Abbreviations 319
Definitions 319
Research Methodology 320
Secondary Research 320
About GlobalData 321
Contact Us 321
Disclaimer 321
Source 322
Read our latest Press
Release at http://www.marketresearchreports.biz/pressreleases
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment